Literature DB >> 20607655

Expression of cannabinoid receptors in human kidney.

Gorka Larrinaga1, Adolfo Varona, Itxaro Pérez, Begoña Sanz, Aitziber Ugalde, M Luz Cándenas, Francisco M Pinto, Javier Gil, José I López.   

Abstract

The presence of CB1 and CB2 cannabinoid receptors and their physiological role in the kidney has been described in animal models but not in humans. Our aim in this study was to evaluate the presence of these receptors in human kidney, adult and fetal. For this purpose, RT-PCR, western-blot and immunohisto-chemical assays were performed. RT-PCR confirmed the presence of CB1 receptor mRNA receptor and the absence of the CB2 receptor mRNA in adult and fetal kidney. Western-blot and immunohistochemical assays revealed the presence of the CB1 cannabinoid receptor protein, which displayed a similar distribution in fetal and adult kidneys. Proximal and distal convoluted tubule cells and intercalated cells in the collecting ducts showed marked positivity. Conversely, the CB2 cannabinoid receptor protein was consistently negative in all cases. Our data suggest a possible implication of the endocannabinoid system in the physiology and development of the human kidney.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607655     DOI: 10.14670/HH-25.1133

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  19 in total

1.  Novel Targets for Therapy of Renal Fibrosis.

Authors:  Niki Prakoura; Juliette Hadchouel; Christos Chatziantoniou
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

2.  Targeted inhibition of the type 2 cannabinoid receptor is a novel approach to reduce renal fibrosis.

Authors:  Lili Zhou; Shan Zhou; Peng Yang; Yuan Tian; Zhiwei Feng; Xiang-Qun Xie; Youhua Liu
Journal:  Kidney Int       Date:  2018-08-06       Impact factor: 10.612

3.  Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

Authors:  Tony Jourdan; Gergő Szanda; Avi Z Rosenberg; Joseph Tam; Brian James Earley; Grzegorz Godlewski; Resat Cinar; Ziyi Liu; Jie Liu; Cynthia Ju; Pál Pacher; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

4.  Cannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma.

Authors:  Gorka Larrinaga; Begoña Sanz; Itxaro Pérez; Lorena Blanco; María L Cándenas; Francisco M Pinto; Javier Gil; José I López
Journal:  J Histochem Cytochem       Date:  2010-09-17       Impact factor: 2.479

Review 5.  Cannabinoids and the kidney: effects in health and disease.

Authors:  Frank Park; Praveen K Potukuchi; Hamid Moradi; Csaba P Kovesdy
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-26

Review 6.  Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers.

Authors:  Shreyas Gandhi; Gaurav Vasisth; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2017-04-11       Impact factor: 1.862

7.  Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD.

Authors:  Shiran Udi; Liad Hinden; Brian Earley; Adi Drori; Noa Reuveni; Rivka Hadar; Resat Cinar; Alina Nemirovski; Joseph Tam
Journal:  J Am Soc Nephrol       Date:  2017-08-31       Impact factor: 10.121

8.  Diuretic effects of cannabinoid agonists in mice.

Authors:  Girish R Chopda; V Kiran Vemuri; Rishi Sharma; Ganesh A Thakur; Alexandros Makriyannis; Carol A Paronis
Journal:  Eur J Pharmacol       Date:  2013-10-05       Impact factor: 4.432

Review 9.  The dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcription.

Authors:  R B Laprairie; M E M Kelly; E M Denovan-Wright
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

10.  Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics.

Authors:  José I López; Marco Schiavo-Lena; Alexandra Corominas-Cishek; Adriana Yagüe; Kevin Bauleth; Rosa Guarch; Ondrej Hes; Regina Tardanico
Journal:  Virchows Arch       Date:  2013-10-19       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.